ConductScience.org, home

Paper5111993

Dopamine: release from the brain in vivo by amantadine.

Von Voigtlander PF and 1 other. Science, 1971. Cited by 96 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Dopamine: release from the brain in vivo by amantadine. Papers, record 5111993. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5111993

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dopamine: release from the brain in vivo by amantadine.
PubMed
Journal
Science
PubMed
Year
1971
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
96
iCite
Relative citation ratio, by iCite
3.21
iCite
Revised in PubMed
2019-06-18
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Von Voigtlander PFP F
2Moore KEK E

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmantadineMajor topic
BrainMajor topic
DopamineMajor topic
Animals
Autoradiography
Cats
Caudate Nucleus
Cerebral Ventricles
Electric Stimulation
Perfusion
Tritium

Source PubMed

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.

PMIDTitleJournalYearIn PapersSource
35,611,807Opening of the Diamondoid Cage upon Ionization Probed by Infrared Spectra of the Amantadine Cation Solvated by Ar, N2 , and H2 O.Chemistry2022https://conductscience.org/library/papers/35611807PubMed
33,624,170Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials.J Neural Transm (Vienna)2021https://conductscience.org/library/papers/33624170PubMed
31,442,412Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.Brain Res2019https://conductscience.org/library/papers/31442412PubMed
29,898,194Potential antidepressant effect of amantadine: a review of preclinical studies and clinical trials.Braz J Psychiatry2018https://conductscience.org/library/papers/29898194PubMed
29,695,911Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson's disease.Ther Clin Risk Manag2018https://conductscience.org/library/papers/29695911PubMed
28,833,562Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3).Mov Disord2017https://conductscience.org/library/papers/28833562PubMed
26,711,850Catecholaminergic based therapies for functional recovery after TBI.Brain Res2016https://conductscience.org/library/papers/26711850PubMed
24,497,943Amantadine ameliorates dopamine-releasing deficits and behavioral deficits in rats after fluid percussion injury.PLoS One2014https://conductscience.org/library/papers/24497943PubMed
22,308,176Targeting Dopamine in Acute Traumatic Brain Injury.Open Drug Discov J2010https://conductscience.org/library/papers/22308176PubMed
21,047,500Traumatic brain injury reduces striatal tyrosine hydroxylase activity and potassium-evoked dopamine release in rats.Brain Res2011https://conductscience.org/library/papers/21047500PubMed
19,580,914Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis.Neurosci Biobehav Rev2009https://conductscience.org/library/papers/19580914PubMed
17,522,851Specific features of sensorimotor cerebral cortex activity modulation by dopamine releaser amantadine.Exp Brain Res2007https://conductscience.org/library/papers/17522851PubMed
10,874,522Tremor-predominant Parkinson's disease. Approaches to treatment.Drugs Aging2000https://conductscience.org/library/papers/10874522PubMed
8,795,596Amantadine hydrochloride treatment in heredodegenerative ataxias: a double blind study.J Neurol Neurosurg Psychiatry1996https://conductscience.org/library/papers/8795596PubMed
8,741,085Amantadine in parkinsonian patients unresponsive to levodopa: a pilot study.J Neurol1996https://conductscience.org/library/papers/8741085PubMed
8,101,093Amantadine and the glutamate hypothesis of schizophrenia. Experiences in the treatment of neuroleptic malignant syndrome.J Neural Transm Gen Sect1993https://conductscience.org/library/papers/8101093PubMed
6,435,991Anti-parkinsonian drugs today.Drugs1984https://conductscience.org/library/papers/6435991PubMed
6,215,256Amantadine modulates phencyclidine binding site sensitivity in rat brain.Experientia1982https://conductscience.org/library/papers/6215256PubMed
6,141,587Evidence for presynaptic antagonism by amantadine of indirectly acting central stimulants.Psychopharmacology (Berl)1984https://conductscience.org/library/papers/6141587PubMed
4,836,359[Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)].Arch Psychiatr Nervenkr (1970)1974https://conductscience.org/library/papers/4836359PubMed

See all 26 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5111993

GET https://conductscience.org/api/papers/v1/5111993/cited_by?page=2